JPRN-UMIN000003428
Recruiting
N/A
A feasibility study of neoadjuvant chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancer - A feasibility study of neoadjuvant chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancer
Toho University school of medicine0 sites20 target enrollmentApril 1, 2010
Conditionsrectal cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- rectal cancer
- Sponsor
- Toho University school of medicine
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Transfusion, blood products, and G\-CSF within 14 days before egistration 2\.History of serious drug hypersensitivity or allergy 3\.Multiple malignancies 4\.Uncontrolled complication of pleural, ascites and pericardium fluid 5\.Infection 6 Current or previous brain and bone metastasis 7\.Serious heart disease such as congestive heart failure, symptomatic coronary artery disease, uncontrolled arrhythmia 8\.Serious hepatic toxicit, pulmonary complaints(interstitial pneumonia) 9\.Serious dysesthesia 10\.Diarrhea 11\.Intestinal paralysis and intestinal obstruction 12\.Evidence of psychiatric disability interfering with enrollment to clinical trial 13\.Uncontrolled diabetic 14\.With atazanavir sulfate. 15\.With TS\-1 16\.Pregnancy 17\.Patients judged inappropriate for this study by physicians
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
A feasibility study of neoadjuvant chemotherapy with docetaxel+cisplatin+capecitabine (DCX) for HER2-negative gastric cancer with macroscopic type 4 and large type 3, or with multiple lymph node metastasisGastric cancerJPRN-UMIN000026783agoya University20
Completed
N/A
Feasibility study of neoadjuvant chemotherapy with docetaxel/CDGP/5-fluorouracil in resectable esophagus canceresophagus cancerJPRN-UMIN000014305Department of Medical Oncology, Sapporo Medical University School of Medicine28
Completed
Phase 2
Feasibility trial of neoadjuvant chemotherapy with docetaxel,cisplatin and fluorouracil for clinical stage II/III esophageal carcinoma.esophageal neoplasmJPRN-UMIN000002396Saitama Cancer Center40
Completed
N/A
Prospective study of neoadjuvant chemotherapy for HER2 positive breast cancer.JPRN-UMIN000046338Sapporo Medical University24
Completed
N/A
A Prospective Study of Neoadjuvant Chemotherapy with Nivolumab/Gemcitabine/Cisplatin in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of BladderKCT0003804Samsung Medical Center48